| 2024-04-16 11:51 | CC:ARCH | Arch Biopartners Inc | 2.38 | News Release200 | Arch adds St. Michael's Hospital to LSALT trial |
| 2024-04-03 10:26 | CC:ARCH | Arch Biopartners Inc | 2.39 | News Release200 | Arch Biopartners welcomes UHN to LSALT phase II |
| 2024-04-02 11:18 | CC:ARCH | Arch Biopartners Inc | 2.30 | News Release200 | Arch Biopartners adds 3 sites to phase 2 LSALT trial |
| 2024-03-18 10:41 | CC:ARCH | Arch Biopartners Inc | 2.20 | News Release200 | Arch publishes phase II LSALT trial data in BMJ Open |
| 2024-03-15 10:10 | CC:ARCH | Arch Biopartners Inc | 2.20 | News Release200 | Arch adds University of Calgary to LSALT trial |
| 2024-03-07 10:24 | CC:ARCH | Arch Biopartners Inc | 1.56 | News Release200 | Arch doses 1st patient in phase II LSALT peptide trial |
| 2024-02-27 12:03 | CC:ARCH | Arch Biopartners Inc | 1.60 | News Release200 | Arch Biopartners completes pre-IND meeting with FDA |
| 2024-01-10 08:45 | CC:ARCH | Arch Biopartners Inc | 1.44 | News Release200 | Arch Biopartners okayed for phase 2 LSALT peptide trial |
| 2024-01-03 10:32 | CC:ARCH | Arch Biopartners Inc | 1.45 | News Release200 | Arch receives Turkish MoH OK for phase II LSALT trial |
| 2023-12-21 11:04 | CC:ARCH | Arch Biopartners Inc | 1.50 | News Release200 | Arch Biopartners receives Turkish LSALT phase II ok |
| 2023-12-18 11:05 | CC:ARCH | Arch Biopartners Inc | 1.45 | News Release200 | Arch Biopartners grants options to buy 350,000 shares |
| 2023-12-13 11:08 | CC:ARCH | Arch Biopartners Inc | 1.44 | News Release200 | Arch Biopartners applies for phase II LSALT trial |
| 2023-11-09 16:34 | CC:ARCH | Arch Biopartners Inc | 1.02 | Shares for Debt330 | Arch Biopartners 156,818 shares for debt |
| 2023-10-24 12:58 | CC:ARCH | Arch Biopartners Inc | 1.09 | News Release200 | Arch to settle $172,500 interest with shares |
| 2023-09-22 09:21 | CC:ARCH | Arch Biopartners Inc | 1.45 | News Release200 | Arch applies for LSALT peptide phase II trial in Turkey |
| 2023-07-31 18:20 | CC:ARCH | Arch Biopartners Inc | 2.07 | News Release200 | Arch Biopartners hires ITG as market-maker |
| 2023-06-27 10:42 | CC:ARCH | Arch Biopartners Inc | 2.14 | News Release200 | Arch Biopartners to proceed with phase 2 LSALT trial |